J9354 — Ado-trastuzumab Emtansine 100 Mg Intravenous Solution
$24,550
All-payer median here
$14,828
Cash / self-pay here
66
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.